The experimental vaccine is being developed by researchers at the University of Oxford, a UK-based research institution, with support from the Coalition for Epidemic Preparedness Innovations (CEPI).
The post Candidate Lassa fever vaccine enters human trials as global health partners outline plans for Nigeria appeared first on Premium Times Nigeria.
